Skip to main content
Rheumatology and Therapy logoLink to Rheumatology and Therapy
. 2015 Feb 24;2(1):97. doi: 10.1007/s40744-015-0009-8

Erratum to: Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis

Philip J Mease 1,
PMCID: PMC4883256

Erratum to: Rheumatol Ther (2014) 1(1–2):1–20 DOI 10.1007/s40744-014-0005-4

The author of the above-mentioned paper would like to make the following correction to the first paragraph of the Acknowledgments section on page 16.

“The author received editorial support in the preparation of this report from Kristin Carlin and Jennifer Schwinn, Peloton Advantage, LLC, Parsippany, NJ, USA, funded by Celgene Corporation, Summit, NJ, USA. The author, however, directed and is fully responsible for all content and editorial decisions for this manuscript. The named author meets the ICMJE criteria for authorship for this manuscript, takes responsibility for the integrity of the work as a whole, and has given final approval for the version to be published.”

Open Access

This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Footnotes

The online version of the original article can be found under doi:10.1007/s40744-014-0005-4.


Articles from Rheumatology and Therapy are provided here courtesy of Springer

RESOURCES